PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and ...
Stocktwits on MSN
UiPath’s AI automation story is not translating into faster growth yet, say UBS, Morgan Stanley analysts
Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...
Martin Oswald, Head of Operational Transformation at Travelodge, explains how a deliberate, colleague-first approach to ...
While conversational AI and agent-based assistants have demonstrated isolated value, scaling AI across the enterprise has remained elusive. Key blockers include security and compliance risks, lack of ...
Zacks Investment Research on MSN
UiPath's AI automation model is driving platform-level efficiency
UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...
UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026.
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the ...
UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results